Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Evaluation of anxiety and depression in patients with morphea taking immunosuppressive drugs during the COVID-19 pandemic
By
- AMS
posted
Oct 01, 2020 07:22 AM
0
Recommend
.
0 comments
0 views
Related Content
2020 global survey from ISAPS sees significant changes in aesthetic procedures during pandemic
- AMS
Added Feb 02, 2022
Blog Entry
Clinical management of psoriasis patients during the COVID-19 pandemic
- AMS
Added Jun 22, 2020
Blog Entry
New Webinar now available
- AMS
Added Jun 04, 2020
Blog Entry
American Society of Plastic Surgeons Unveils COVID-19’s Impact and Pent-Up Patient Demand Fueling the Industry's Current Post-Pandemic Boom
- AMS
Added May 18, 2021
Blog Entry
American Society of Plastic Surgeons Releases New Guidance for Resuming Elective Procedures Amid COVID-19
- AMS
Added Jun 17, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic